TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
IPSC

Century Therapeutics Inc

Healthcare · Biotechnology

1.70$ +3.6% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IPSC
Line item 2015 2016 2019 2020 2021 2022 2023 2024 2025
11.0% – – – -8,412.3% 270.3% -3,952.9% -1,671.5% -95.2%
– – – – 354.3% 162.3% 583.6% 201.9% 12.0%
– – – – 440.6% 205.2% 654.2% 192.6% 6.3%
– – – – 440.6% 205.2% – – –
– – – – -264.4% 2,384.0% 419.7% -140.8% -104.9%
3.1% 2.4% – – 4,250.5% 588.7% 614.6% 2.3% 0.8%
– – – – -28,198.3% -252.5% 2,735.2% 720.6% 98.5%
– – – – 21,164.5% 522.4% – – –
– – – – 0.0% 0.0% -458.2% 0.0% –
– 20.9% – – 39,487.1% 522.4% -435.1% 1,131.6% 0.2%
– – – – 2,876.6% 540.1% -1,652.8% 180.8% 3.5%
– – – – -12,662.8% -318.4% -4,567.5% -1,673.8% -95.9%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?